- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Non-squamous Non-small Cell Lung Cancer in Netherlands
Total 426 results
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung Cancer, Solid CancersUnited States, Netherlands
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerNetherlands
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerNetherlands, United Kingdom
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerUnited States, France, Netherlands
-
Amsterdam UMC, location VUmcBoehringer IngelheimRecruitingAdvanced Stage Non-small Cell Lung CancerNetherlands
-
The Netherlands Cancer InstituteCompletedInoperable Locally Advanced Non Small Cell Lung CancerNetherlands
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
Radboud University Medical CenterCompletedNSCLC | Locally Advanced Non-Small Cell Lung CancerNetherlands
-
BayerCompletedHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationNetherlands
-
Maastricht Radiation OncologyCompletedNon-small Cell Lung CancerNetherlands
-
Boehringer IngelheimRecruitingMelanoma | Non-small Cell Lung Cancer (NSCLC) | Carcinoma, Squamous Cell of Head and Neck (HNSCC)Netherlands
-
Radboud University Medical CenterAstraZenecaCompletedNon-small Cell Lung CancerNetherlands
-
Radboud University Medical CenterMerck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung CancerNetherlands
-
Maastricht Radiation OncologyCompleted
-
Maastricht Radiation OncologyCompleted
-
Maastricht Radiation OncologyWithdrawn
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Canada, Austria, Finland, France, Greece, Korea, Republic of, Panama, Portugal, Spain, Turkey, United Kingdom, Taiwan, Brazil, Germany, Poland, Chile, Guatemala, Russian Federation, Switzerland, Thailand, Ukraine, Serb... and more
-
Maastricht Radiation OncologyCompleted
-
Maastricht Radiation OncologyAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Maastro...Completed
-
Maastricht Radiation OncologyMerck Sharp & Dohme LLC; Academisch Ziekenhuis MaastrichtCompleted
-
AbbVieCompletedNon-squamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Czechia, Denmark, Finland, Germany, Hungary, Israel, Japan, Korea, Republic of, Netherlands, New Zealand, Russian Federation, South Africa, Spain, Taiwan, Turkey, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania
-
Maastricht Radiation OncologyUniversity of PennsylvaniaCompletedNon Small Cell Lung CancerNetherlands
-
Maastricht Radiation OncologyUniversity Medical Center Groningen; The Netherlands Cancer InstituteCompletedNon Small Cell Lung Cancer (NSCLC) | Stage III Non-Small Cell Lung Cancer | Radical TreatmentNetherlands
-
Frame Pharmaceuticals B.V.University Medical Center Groningen; Erasmus Medical Center; The Netherlands... and other collaboratorsNot yet recruiting
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Italy, Spain, Czechia, Hungary, Netherlands, Canada, Australia, Austria, Belgium, Germany, Ireland, Israel, Poland, United Kingdom, Taiwan, Portugal
-
Amsterdam UMC, location VUmcMerck Sharp & Dohme LLCUnknownNon Small Cell Lung CancerNetherlands
-
UMC UtrechtUnknown
-
Erasmus Medical CenterRecruiting
-
Erasmus Medical CenterRecruitingNon-small Cell Lung CancerNetherlands
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerFrance, Germany, Spain, Sweden, Russian Federation, Greece, Switzerland, Korea, Republic of, Italy, Netherlands, Turkey, United Arab Emirates
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
ETOP IBCSG Partners FoundationHoffmann-La RocheTerminatedNon-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentIreland, Spain, Belgium, Italy, Netherlands, Switzerland
-
Maastricht Radiation OncologyCompletedStage I-III Non-small Cell Lung CancerNetherlands
-
Radboud University Medical CenterTerminatedStage III Non-small Cell Lung Cancer | Individualized Radiation Dose EscalationNetherlands
-
Academisch Ziekenhuis MaastrichtThe Netherlands Cancer Institute; ZonMw: The Netherlands Organisation for Health...Completed
-
Maastricht Radiation OncologyCompletedNon-small Cell Lung CancerNetherlands
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, Italy, China, Korea, Republic of, Canada, Japan, Netherlands
-
University Medical Center GroningenRecruitingNon Small Cell Lung Cancer MetastaticNetherlands
-
Maastricht Radiation OncologyAnticancer Fund, Belgium; Reliable Cancer TherapiesTerminatedNon Small Cell Lung Cancer (NSCLC)Netherlands
-
Merck KGaA, Darmstadt, GermanyCompletedLung Cancer | Non Small Cell Lung CancerNetherlands
-
ArriVent BioPharma, Inc.Allist Pharmaceuticals, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | EGFR Exon 20 MutationsUnited States, Australia, Spain, France, Italy, China, Japan, Korea, Republic of, Malaysia, Netherlands, Philippines, Singapore, Taiwan, Thailand, Brazil, Israel, United Kingdom
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Italy, Korea, Republic of, Poland, Russian Federation, Spain, United Kingdom, China, Romania, Netherlands, Hong Kong, Austria, Belgium, Czechia, Hungary, Portugal, Greece, Germany, Ireland, Switze... and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, France, Austria, Denmark, Italy, Spain, Germany, Mexico, Netherlands, Japan, Brazil, Greece, Argentina, Slovakia, Lebanon, Belgium, Oman, United Arab Emirates
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerAustralia, France, Germany, Spain, China, Hong Kong, Canada, Sweden, Colombia, Taiwan, United Kingdom, Russian Federation, Finland, Austria, Estonia, Hungary, Netherlands, Latvia, Italy, Mexico, Slovenia, Turkey, Bosnia and Herzegovina and more
-
Maastricht University Medical CenterRecruitingNon-small Cell Lung CancerNetherlands
-
Prelude TherapeuticsRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Non-small Cell Lung Cancers | SMARCA4 Gene MutationUnited States, France, Spain, Singapore, Netherlands
-
Erasmus Medical CenterRecruitingNon Small Cell Lung Cancer | Liquid Biopsy | Tyrosine Kinase InhibitorNetherlands
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownNon Small Cell Lung Cancer (NSCLC) | Intrathoracic Nodal StagingNetherlands, Poland